This chemical is primarily used in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) that target specific biological pathways. It serves as a key intermediate in the production of drugs that modulate neurotransmitter systems, potentially aiding in the treatment of neurological disorders such as depression, anxiety, or Parkinson's disease. Additionally, its structure, featuring a bromophenyl group and a protected amino acid moiety, makes it valuable in peptide chemistry for constructing complex peptide-based therapeutics. Its tert-butoxycarbonyl (Boc) protecting group allows for selective deprotection, enabling precise control during multi-step synthetic processes. This compound is also utilized in research settings for studying enzyme interactions and designing inhibitors for specific enzymes involved in disease mechanisms.